Trade Summary

5 days ago, PATOU GARY, serving as Dir at Xenon Pharmaceuticals Inc. (XENE), sold 1,322 shares at $53.14 per share, for a total transaction value of $70,251.08. Following this transaction, PATOU GARY now holds 24,896 shares of XENE.

This sale represents a 5.04% decrease in PATOU GARY's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, June 5, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, June 9, 2026 (accepted Jun 8, 9:19 PM ET), 4 days after the trade was made.

Xenon Pharmaceuticals Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.